article thumbnail

FDA grants swift approval to Cognoa’s digital device for autism diagnosis

pharmaphorum

The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval. Instead, doctors have to look at a child’s developmental history and behaviour over time before making a diagnosis.

Doctors 101
article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

We can use the content of the EHRs via artificial intelligence which benefits doctors’ time, and their ability to do research. I started talking about it with other doctors and thought ‘What if we applied some sort of computational linguistics?’ The technology is being embraced by doctors around the world according to Medrano.

Doctors 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 109
article thumbnail

SurgAR and Medexprim start surgical AR partnership with French hospital

pharmaphorum

France’s SurgAR has joined with imaging data firm Medexprim to form a three-year partnership with a major hospital in France, to develop augmented reality (AR) software dedicated to laporoscopic surgery. The information comes from preoperative radiological imaging data and aims to guide the surgeon during operations, increasing precision.

article thumbnail

Disrupted medical conferences: 2022 and beyond

pharmaphorum

According to the 1 st Ashfield-IPCAA survey of over 300 doctors who had attended virtual conferences in 2020, pharma’s sponsored symposia were generally well received but its virtual exhibition stands were not. These methods have consistently been found not to alter doctors’ behaviours, improve clinical performance or change patient outcomes.

Doctors 98
article thumbnail

MIOTIFY platform for digital health products clears AZ road test

pharmaphorum

UK company MIOTIFY has developed a web-based software platform that product teams can use to configure medical algorithms quickly, create code packages to harness them and generate supporting documentation – all in a format that is designed to meet regulatory requirements for software as a medical device (SaMD). .

article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. As we develop these technologies, it’s not only that we must focus on the patient experience; we need to start with the patient experience,” Hadjiat tells pharmaphorum.